Fasiha Kanwal
#141,555
Most Influential Person Now
Researcher
Fasiha Kanwal's AcademicInfluence.com Rankings
Fasiha Kanwalengineering Degrees
Engineering
#5326
World Rank
#6576
Historical Rank
Electrical Engineering
#1472
World Rank
#1566
Historical Rank
Fasiha Kanwalcomputer-science Degrees
Computer Science
#6817
World Rank
#7182
Historical Rank
Computational Linguistics
#1259
World Rank
#1273
Historical Rank
Machine Learning
#2336
World Rank
#2365
Historical Rank
Artificial Intelligence
#2611
World Rank
#2652
Historical Rank
Download Badge
Engineering Computer Science
Fasiha Kanwal's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Fasiha Kanwal Influential?
(Suggest an Edit or Addition)Fasiha Kanwal's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. (2012) (651)
- Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents. (2017) (610)
- Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go? (2014) (516)
- Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. (2016) (445)
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. (2018) (394)
- Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. (2011) (390)
- Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment (2005) (378)
- Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. (2017) (342)
- Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States (2015) (326)
- Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection (2016) (318)
- Global epidemiology and burden of HCV infection and HCV-related disease (2017) (310)
- Utilization of Surveillance for Hepatocellular Carcinoma Among Hepatitis C Virus–Infected Veterans in the United States (2011) (294)
- HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV (2014) (266)
- Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction. (2019) (254)
- Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. (2015) (218)
- Post‐Transplant Diabetes Mellitus and HCV Seropositive Status After Renal Transplantation: Meta‐Analysis of Clinical Studies (2005) (178)
- Advancing the global public health agenda for NAFLD: a consensus statement (2021) (167)
- Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States (2018) (158)
- A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis. (2014) (150)
- Long‐Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents (2020) (147)
- Treatment Alternatives for Chronic Hepatitis B Virus Infection: A Cost-Effectiveness Analysis (2005) (144)
- Hepatitis C Disease Burden in the United States in the era of oral direct‐acting antivirals (2016) (139)
- HBsAg Seropositive Status and Survival After Renal Transplantation: Meta‐Analysis of Observational Studies (2005) (134)
- Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network (2009) (127)
- Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease (2020) (125)
- Predictors of treatment in patients with chronic hepatitis C infection—Role of patient versus nonpatient factors (2007) (125)
- Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. (2016) (124)
- The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. (2012) (123)
- Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort. (2016) (119)
- Health-related quality of life predicts mortality in patients with advanced chronic liver disease. (2009) (115)
- An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. (2010) (114)
- The impact of hepatitis C burden: an evidence‐based approach (2014) (114)
- Women have Lower Risk of Nonalcoholic Fatty Liver Disease but Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. (2020) (112)
- Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting (2015) (109)
- Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review. (2016) (99)
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. (2021) (99)
- Gaps in the achievement of effectiveness of HCV treatment in national VA practice. (2012) (97)
- Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance (2017) (96)
- Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. (2017) (95)
- Insurance status and treatment candidacy of hepatitis C patients: Analysis of population‐based data from the United States (2011) (94)
- Treatment Alternatives for Hepatitis B Cirrhosis: A Cost-Effectiveness Analysis (2006) (94)
- Boceprevir and telaprevir in the management of hepatitis C virus-infected patients. (2012) (92)
- Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran’s Affairs Health Care System (2018) (91)
- AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review. (2019) (84)
- Importance of Patient, Provider, and Facility Predictors of Hepatitis C Virus Treatment in Veterans: A National Study (2011) (83)
- Increased risk of pancreatic adenocarcinoma after acute pancreatitis. (2014) (83)
- A comparison of liver transplantation outcomes in the pre‐ vs. post‐MELD eras (2005) (82)
- Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list (2017) (82)
- Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. (2019) (81)
- Impact of nasogastric lavage on outcomes in acute GI bleeding. (2011) (80)
- Are Physician-Derived Disease Severity Indices Associated with Health-Related Quality of Life in Patients with End-Stage Liver Disease? (2004) (79)
- Racial Differences in the Progression to Cirrhosis and Hepatocellular Carcinoma in HCV-Infected Veterans (2014) (79)
- The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal. (2004) (77)
- "Systematic Reviews and Meta-analyses" in Clinical Gastroenterology and Hepatology. (2012) (75)
- Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysis. (2006) (75)
- Hepatocellular carcinoma screening in patients waiting for liver transplantation: A decision analytic model (2003) (72)
- Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004-2013. (2018) (68)
- Dietary quality and the colonic mucosa-associated gut microbiome in humans. (2019) (68)
- Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia (2016) (67)
- Early outpatient follow‐up and 30‐day outcomes in patients hospitalized with cirrhosis (2016) (66)
- Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus‐infected patients (2014) (66)
- Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases (2019) (64)
- Cirrhosis is under‐recognised in patients subsequently diagnosed with hepatocellular cancer (2016) (61)
- Development and validation of a disease‐targeted quality of life instrument in chronic hepatitis B: The hepatitis B quality of life instrument, version 1.0 (2007) (61)
- Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection (2011) (61)
- Early Impact of COVID-19 on Solid Organ Transplantation in the United States (2020) (59)
- The Impact of Somatization on the Use of Gastrointestinal Health-Care Resources in Patients with Irritable Bowel Syndrome (2005) (59)
- Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta‐analysis (2017) (58)
- Barriers to hepatitis C treatment in the era of direct‐acting anti‐viral agents (2017) (54)
- Hepatitis C Virus Infection and Coronary Artery Disease Risk: A Systematic Review of the Literature (2014) (53)
- Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus. (2016) (52)
- Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey (2019) (51)
- Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: Effect of patient and nonpatient factors (2013) (51)
- Positive Predictive Value of International Classification of Diseases, 10th Revision, Codes for Cirrhosis and Its Related Complications (2018) (50)
- Lack of association between hepatitis C infection and chronic kidney disease. (2010) (50)
- The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage. (2006) (49)
- Transplanting hepatitis C virus–positive livers into hepatitis C virus–negative patients with preemptive antiviral treatment: A modeling study (2018) (48)
- Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failuare. (2020) (48)
- Measuring Quality of Care in Patients With Nonvariceal Upper Gastrointestinal Hemorrhage: Development of an Explicit Quality Indicator Set (2010) (47)
- Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection (2017) (44)
- Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013 (2017) (43)
- Patient‐reported outcomes in cirrhosis: A scoping review of the literature (2018) (43)
- Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement (2021) (42)
- Impact of COVID‐19 Pandemic on Liver Transplantation and Alcohol‐Associated Liver Disease in the USA (2021) (41)
- The effects of sustained virological response to direct‐acting anti‐viral therapy on the risk of extrahepatic manifestations of hepatitis C infection (2019) (41)
- New Diagnosis of Chronic Pancreatitis: Risk of Missing an Underlying Pancreatic Cancer (2014) (40)
- Major stigmata of recent hemorrhage on rectal ulcers in patients with severe hematochezia: Endoscopic diagnosis, treatment, and outcomes. (2003) (39)
- The Quality of Care Provided to Patients With Varices in the Department of Veterans Affairs (2014) (38)
- Epidemiology and outcomes of hepatitis C infection in elderly US Veterans (2016) (38)
- Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C. (2015) (38)
- Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda. (2020) (36)
- Dietary Nutrients Involved in One-Carbon Metabolism and Colonic Mucosa-Associated Gut Microbiome in Individuals with an Endoscopically Normal Colon (2019) (36)
- Impact of Chronic Viral Hepatitis on Health-Related Quality of Life in HIV: Results from a Nationally Representative Sample (2005) (36)
- Obesity and hepatocellular carcinoma: Hype and reality (2014) (36)
- Quality of Care in Patients With Chronic Hepatitis C Virus Infection (2010) (36)
- Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease (2021) (35)
- The impact of direct‐acting anti‐virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States (2019) (35)
- A model to predict the development of mental status changes of unclear cause after liver transplantation (2003) (34)
- Improving quality of health care for patients with cirrhosis. (2014) (33)
- Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study (2019) (33)
- Relevance of low testosterone to nonalcoholic fatty liver disease (2015) (32)
- Real‐world effectiveness of elbasvir/grazoprevir In HCV‐infected patients in the US veterans affairs healthcare system (2018) (32)
- α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it. (2013) (32)
- The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis. (2015) (31)
- Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes (2020) (30)
- Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study (2018) (29)
- Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality (2020) (29)
- Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan (2019) (29)
- Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases (2021) (29)
- Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans with Cirrhosis. (2019) (27)
- AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis (2022) (27)
- Viral RNA testing in hepatitis C antibody-positive veterans. (2009) (26)
- The end of hepatitis C. (2014) (25)
- Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study (2019) (23)
- Preparing for the NASH Epidemic: A Call to Action. (2021) (23)
- Decreasing mortality in patients hospitalized with cirrhosis. (2015) (23)
- Screening High Risk Individuals for Hepatitis B: Physician Knowledge, Attitudes, and Beliefs (2011) (23)
- Uvular necrosis after upper endoscopy: a case report and review of the literature. (2002) (22)
- Hepatitis C virus re‐treatment in the era of direct‐acting antivirals: projections in the USA (2018) (22)
- Cost Effectiveness of Pre– vs Post–Liver Transplant Hepatitis C Treatment With Direct‐Acting Antivirals (2018) (22)
- Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey (2017) (22)
- Preparing for the NASH epidemic: A call to action. (2021) (22)
- Cost Effectiveness of Transplanting HCV‐Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy (2019) (22)
- Hepatocellular Carcinoma Screening Practices in the Department of Veterans Affairs: Findings from a National Facility Survey (2013) (22)
- Trends in Outcomes for Marginal Allografts in Liver Transplant. (2020) (21)
- On the proposed definition of metabolic associated fatty liver disease. (2021) (21)
- Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings from Texas Hepatocellular Carcinoma Consortium Cohort. (2020) (20)
- Prediction Models for Gastrointestinal and Liver Diseases: Too Many Developed, Too Few Validated. (2016) (20)
- Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing (2017) (20)
- Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis (2016) (20)
- The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC). A Phase 3 Biomarker Study in the United States. (2022) (18)
- Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males. (2014) (18)
- The Performance of Process Measures in Hepatitis C (2012) (18)
- Quality of Care in the Cirrhotic Patient (2016) (18)
- Hepatitis C virus treatment: the unyielding chasm between efficacy and effectiveness. (2014) (17)
- Process of care for hepatitis C infection is linked to treatment outcome and virologic response. (2012) (17)
- Nutrition in Alcoholic Liver Disease: An Update. (2019) (16)
- Surveillance for hepatocellular carcinoma: can we focus on the mission? (2015) (16)
- Hepatitis C and Risk of Nonhepatic Malignancies. (2017) (15)
- Clinical Factors Associated With Lack of Serological Response to SARS‐CoV‐2 Messenger RNA Vaccine in Liver Transplantation Recipients (2021) (15)
- Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis (2020) (15)
- Factors Associated With Access to and Receipt of Liver Transplantation in Veterans With End-Stage Liver Disease. (2021) (14)
- Risk factors for HCC in contemporary cohorts of patients with cirrhosis (2022) (14)
- Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers (2016) (13)
- Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population (2018) (12)
- Pay for Performance in Chronic Liver Disease. (2015) (12)
- Acculturation and Nonalcoholic Fatty Liver Disease Risk Among Hispanics of Mexican Origin: Findings From the National Health and Nutrition Examination Survey (2017) (12)
- Why We Should Be Willing to Pay for Hepatitis C Treatment. (2015) (11)
- Integrated Model for Patient-Centered Advanced Liver Disease Care. (2020) (11)
- Hepatocellular cancer care: cost is important but only one factor of disease burden. (2009) (11)
- Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities. (2014) (11)
- Implementation of a Population‐Based Cirrhosis Identification and Management System (2018) (11)
- Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication. (2022) (10)
- Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group. (2017) (10)
- Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents (2019) (10)
- Preparing for the NASH Epidemic: A Call to Action (2021) (10)
- Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort (2022) (10)
- Coordinating care in patients with cirrhosis. (2013) (10)
- Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases (2021) (10)
- Patient-reported outcomes of cirrhosis. (2013) (10)
- Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents (2020) (9)
- Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-based Cohort of Patients With Cirrhosis of Multiple Etiologies. (2020) (9)
- Patient‐reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases (2022) (9)
- Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA (2020) (9)
- Quality of Care Indicators in Patients with Acute Pancreatitis (2019) (9)
- Trends in Outcomes for Marginal Allografts in Liver Transplant. (2020) (8)
- Obesity and Risk of Nonalcoholic Fatty Liver Disease: A Comparison of Bioelectrical Impedance Analysis and Conventionally‐Derived Anthropometric Measures (2017) (8)
- Transforming strategies for the prevention of chronic HBV and HCV infections. (2010) (8)
- Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population. (2019) (8)
- CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. (2013) (8)
- Renal Trajectory Patterns Are Associated With Post-Discharge Mortality in Patients with Cirrhosis and Acute Kidney Injury. (2019) (8)
- Qualitative analysis of patient-centered decision attributes associated with initiating hepatitis C treatment (2015) (8)
- The Validity of HCC Diagnosis Codes in Chronic Hepatitis B Patients in the Veterans Health Administration (2017) (8)
- Collaborative Care for Depression in Chronic Hepatitis C Clinics. (2016) (8)
- CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. (2013) (7)
- National patterns and predictors of liver biopsy use for management of hepatitis C. (2012) (7)
- Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States. (2021) (7)
- A Randomized Trial of Off-Site Collaborative Care for Depression in Chronic Hepatitis C Virus. (2018) (7)
- Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV (2016) (7)
- Spatial Characteristics of Colonic Mucosa-Associated Gut Microbiota in Humans (2021) (7)
- Unconscious Bias in Peer Review. (2020) (6)
- Quality of care assessment in chronic liver disease (2014) (6)
- A Roadmap for Value‐Based Payment Models Among Patients With Cirrhosis (2019) (6)
- Impact of Hepatitis C on Health Related Quality of Life (2005) (6)
- Hepatitis C virus‐related complications are increasing in women veterans: A national cohort study (2017) (6)
- Oral Health and the Altered Colonic Mucosa-Associated Gut Microbiota (2020) (5)
- Improving quality of care in patients with cirrhosis (2013) (5)
- Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease (2020) (5)
- Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection (2015) (5)
- Dietary Fatty Acid Intake and the Colonic Gut Microbiota in Humans (2022) (5)
- Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA. (2021) (5)
- Antiviral Treatment for Hepatitis C Virus is Associated With a Reduced Risk of Hepatocellular Carcinoma in a National Cohort of U.S. Veterans (2011) (5)
- 4 - Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer (HCC) in Non-Alcoholic Fatty Liver Disease (NAFLD) (2018) (4)
- Association Between Facility Characteristics and the Process of Care Delivered to Patients with Hepatitis C Virus Infection (2014) (4)
- The HCV Treatment Cascade: Race Is a Factor to Consider (2019) (4)
- Effectiveness of Elbasvir/Grazoprevir in US Veterans with Chronic Hepatitis C Virus Genotype 1b Infection (2020) (4)
- A practical use of noninvasive tests in clinical practice to identify high‐risk patients with nonalcoholic steatohepatitis (2022) (4)
- Primary prophylaxis of variceal bleeding. (2014) (4)
- Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes (2022) (3)
- SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation (2021) (3)
- Does Treatment Alter the Natural History of Chronic HCV (2012) (3)
- Quality of Care Provided to Patients with Chronic Hepatitis B Virus Infection (2017) (3)
- Real world experience with elbasvir/grazoprevir in the Veterans Affairs Healthcare System (2017) (3)
- Use of Hy's Law, R criteria, and nR criteria to predict acute liver failure or transplantation in patients with drug-induced liver injury. (2015) (3)
- Phase 3 biomarker study for HCC surveillance using AFP, AFP L-3 and DCP. A prospective collection with retrospective blinded evaluation (2017) (3)
- Absolute Risk of Hepatocellular Carcinoma in a Large, Geographically and Ethnically Diverse Cohort of Patients with Non-Alcholic Fatty Liver Disease (2017) (3)
- Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization (2019) (3)
- MEASURING HEALTH-RELATED QUALITY OF LIFE IN GASTROENTEROLOGY AND HEPATOLOGY: PART 2–WHAT IS AVAILABLE? (2003) (3)
- Corrigendum: New Diagnosis of Chronic Pancreatitis: Risk of Missing an Underlying Pancreatic Cancer (2015) (3)
- 636 HCC in the Absence of Cirrhosis in United States Veterans: an Emerging Disease Entity Associated With Features of Metabolic Syndrome (2014) (3)
- Health Related Quality of Life in Patients with Cirrhosis (2014) (2)
- Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. (2022) (2)
- Retrospective analysis of long‐term outcome 10 years after liver transplantation for Wilson disease: experience over three decades (2020) (2)
- PS-182-Effectiveness of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 infection who receive opioid agonist therapy: Treatment utilization and the impact of concomitant psychiatric medications (2019) (2)
- NAFLD and HCC: Time to Bridge the Gap (2021) (2)
- Changing epidemiology of hepatocellular cancer in the United States: Winning the battle but it is not over yet (2022) (2)
- Projection of patients who fail treatment in the era of direct-acting antivirals (2017) (2)
- Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis (2018) (2)
- Marginal allografts in liver transplantation have a limited impact on length of stay (2021) (2)
- Cost-effectiveness and Decision Analysis in Clinical Gastroenterology and Hepatology: From Evidence to Informed Decision Making. (2017) (2)
- Skin Disorders in Elderly Population Attending Tertiary Care Hospital in Karachi (2016) (2)
- 117 Risk Assessment in Acute Non-Variceal Upper Gastrointestinal Hemorrhage: Validation of the AIMS65 Score (2012) (2)
- Adding to the evidence base: Effectiveness of hepatocellular carcinoma surveillance in clinical practice (2017) (2)
- Communication and trust: Critically important to eliminate disparities in liver transplantation (2016) (2)
- Prognosis conversations in advanced liver disease: A qualitative interview study with health professionals and patients (2022) (2)
- Preparing for the NASH epidemic: A call to action (2021) (2)
- 775 Beverage Intake and the Risk of Advanced Fibrosis in HCV: Coffee, Tea, or Sodas? (2014) (2)
- Leveraging Telemedicine for Quality Assessment (2022) (2)
- Sa1061 Nonalcoholic Fatty Liver Disease (NAFLD) in the Veterans Administration Population: Development and Validation of an Algorithm for NAFLD Using Automated Data (2014) (2)
- HP QI Abstract: Improving Helicobacter pylori Testing in Patients With Acute Upper GI Bleeding Due to Peptic Ulcer Disease (2020) (2)
- The Top Five Reasons You Should Publish in Clinical Gastroenterology and Hepatology. (2017) (2)
- Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC) (2022) (2)
- Tu1489 - Improved Treatment Delivery and Overall Survival Associated with Multidisciplinary Tumor Board Evaluation of Patients with Advanced Hepatocellular Carcinoma (2018) (1)
- Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatocellular Carcinoma: How Common? (2015) (1)
- Project ECHO: The Specialist Will See You Now (2018) (1)
- T1948 Early Endoscopy Predicts Lower Mortality in Acute Gastrointestinal Hemorrhage (2009) (1)
- Prevalence and Short-term Mortality of Acuteon-Chronic Liver Failure (ACLF) in the Veterans Affairs Hospitals (2004-2014): a National US Cohort. (2017) (1)
- Hepatology in a changing health care landscape: A call for health services research (2018) (1)
- THU-171-Effectiveness of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 infection receiving dialysis (2019) (1)
- 709 HCV Treatment and SVR: Gaps in the Face of Achieving Effectiveness in Practice (2010) (1)
- 704 Impact of Active Hepatitis B Virus DNA Replication on Clinical Outcomes in Patients With Hepatitis C and B Co-Infection (2014) (1)
- Making a Great Journal Even Better. (2017) (1)
- Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population (2022) (1)
- Contemporary changes in etiology for hepatocellular carcinoma in liver transplantation. (2022) (1)
- 12 The Risk Factors of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic Chronic Hepatitis B Patients in United States Veterans (2016) (1)
- Reply to: "Hepatocellular carcinoma (HCC) in the absence of cirrhosis in patients with chronic hepatitis B virus infection". (2017) (1)
- Validation of International Classification of Disease, 10 th Version (ICD-10) Codes for Cirrhosis and its Complications (2017) (1)
- The Art and Science of Managing Liver Disease. (2015) (1)
- Response to Li et al. (2015) (1)
- Cost-Effectiveness in Hepatitis B (2005) (1)
- The Risk of Hepatocellular Carcinoma in Entecavir versus Tenofovir Treated U.S. Cohort with Chronic Hepatitis B Virus. (2022) (1)
- The prevalence and determinants of NAFLD and MAFLD and their severity in the VA primary care setting. (2022) (1)
- Improved Survival after Liver Transplantation for Patients with HIV and HIV/HCV Coinfection in the INSTI and DAA eras. (2022) (1)
- Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma (2020) (1)
- MEASURING HEALTH-RELATED QUALITY OF LIFE IN GASTROENTEROLOGY AND HEPATOLOGY: PART 1 (2002) (1)
- Timely Endoscopy Depends on Quality of Early Resuscitation and Pre-Endoscopic Care in Nonvariceal Upper GI Hemorrhage (2011) (1)
- 62 Measuring Quality of Care in Patients with Cirrhosis: Development of An Explicit Quality Indicator Set (2009) (1)
- Standardizing the Removal of Large Colon Polyps: An Evidence-Based Approach (2018) (1)
- Mo1494 Natural History of Untreated HCC in a U.S. Cohort and the Role of Cancer Surveillance (2016) (1)
- Underestimation of cirrhosis related mortality in the Medicare eligible population, 1999-2018. (2021) (1)
- Tu1030 The Adjusted AFP Algorithm Improves the Predictive Value for HCC During Surveillance (2013) (1)
- Nonalcoholic fatty liver disease and Hepatocellular Carcinoma: Time to Bridge the Gap. (2021) (1)
- Elevated serum sodium in recipients of liver transplantation has a substantial impact on outcomes (2021) (1)
- A Web-Based, Population-Based Cirrhosis Identification and Management System for Improving Cirrhosis Care: Qualitative Formative Evaluation (2021) (1)
- Performance of AFP-Based Hepatocellular Carcinoma Surveillance in Cirrhosis Patients with Cured HCV (2017) (1)
- Correction to: Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis (2020) (1)
- Perceptions of weight status and energy balance behaviors among patients with non-alcoholic fatty liver disease (2022) (1)
- The Influence of Gut and Tumor Microbiome on Pancreatic Cancer Outcomes. (2020) (1)
- Reply to: "Inappropriate use of FIB-4 index for cirrhosis detection in hepatocellular carcinoma patients". (2017) (1)
- Reply to: "Prevalence and short-term mortality in a national US cohort with acute-on-chronic liver failure". (2019) (1)
- S1229 Risk Factors for Recurrent Clostridium difficile-Associated Diarrhea: A Retrospective Case-Control Study (2010) (1)
- Sa1523 COMPARATIVE EFFECTIVENESS OF TENOFOVIR VS. ENTECAVIR IN REDUCING THE RISK OF HEPATOCELLULAR CARCINOMA IN A US COHORT OF PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION (2020) (1)
- THU-170-Real-world effectiveness of elbasvir/grazoprevir in patients with hepatitis C virus genotype 4 infection: Results from a Veterans Affairs population (2019) (1)
- Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS‐CoV‐2 Infection (2021) (1)
- Why Do Small Intraductal Papillary Mucinous Neoplasms Create Such a Huge Management Challenge? (2022) (1)
- Tu1005 Outcomes Associated With Co-Utilization of VA and Medicare Healthcare Benefits in Patients With Hepatocellular Carcinoma (2014) (1)
- Sa1067 IMPLEMENTATION OF A FIRST-YEAR GASTROENTEROLOGY FELLOWS' RETREAT: EXPERIENCE AND FEEDBACK FROM THE FIRST TWO YEARS (2020) (0)
- Measuring the Quality of Palliative Care for Patients with End Stage Liver Disease (S861) (2019) (0)
- ARandomized Trial of Off-Site Collaborative Care for Depression in Chronic Hepatitis CVirus (2018) (0)
- Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality (2022) (0)
- Su1486 Ongoing Increases in HCC Incidence Disproportionately Impact Specific Sub-Groups and Geographic Regions (2016) (0)
- Tu1061 Angiotensin Converting Enzyme Inhibitors (Acei) Are Not Associated With Severity of Fibrosis in Patients With Hepatitis C Virus (HCV) (2015) (0)
- Post-transplant outcomes for alcohol-associated liver disease during the COVID-19 pandemic. (2023) (0)
- Specialty Evaluation in Patients With Chronic Hepatitis C Virus Infection—Role of Patient Versus Non-Patient Factors (2011) (0)
- 384: EFFECT OF THE INTERPLAY BETWEEN PNPLA3 I148M VARIANT, ALCOHOL INTAKE, AND OBESITY ON THE RISK OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (2022) (0)
- Tu1053 HCV-Related Complications Are Increasing in Women Veterans: A National Cohort Study (2015) (0)
- 1005 Patient Race and Risk of Cirrhosis and Hepatocellular Cancer in a National Sample of Veterans With HCV (2014) (0)
- Response to letter to the editor from Zhou et al (Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease). (2022) (0)
- One Year Risk Trajectories of Mortality and Readmission in Patients with Cirrhosis-Related Hospitalizations (2017) (0)
- Tu1010 Automated Data Underestimate Quality of Care in HCV (2012) (0)
- T1000 Utilization of Surveillance for Hepatocellular Carcinoma Among HCV Infected Patients in the United States (2010) (0)
- Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma (2021) (0)
- Tu1491 – Use of Androgen Lowering Medications Finasteride and Dutasteride Do Not Substantially Alter Risk of Incident Hcvrelated Hepatcellular Carcinoma in Men (2019) (0)
- Reply to: "Mortality of acute-on-chronic liver failure: What is the role of obesity?" (2019) (0)
- Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma (2022) (0)
- 505 COMPARATIVE PERFORMANCE OF PREDICTION MODELS OF HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA IN THE UNITED STATES POPULATION (2021) (0)
- 1112 Recipient characteristics and post-liver transplantation (LT) outcomes before and after MELD (2003) (0)
- S1140 Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplant Recipients With SARS-CoV-2 Infection (2021) (0)
- T1004 Over-Utilization of Hepatitis C Antibody Testing and Its Impact on the Quality of Care in Patients With Chronic Hepatitis C Virus Infection (2010) (0)
- Tu1011 Quality of Varices-Related Care in Patients With Cirrhosis (2012) (0)
- Tu1004 Nonalcoholic Fatty Liver Disease Is Underrecognized in the Primary Care Setting (2014) (0)
- Spatial Characteristics of Colonic Mucosa-Associated Gut Microbiota in Humans (2021) (0)
- S2085 Prevalence of Celiac Disease in Established Liver Disease and Cryptogenic Transaminase Elevation: A Systematic Review (2008) (0)
- S2077 Are High Risk Individuals Appropriately Screened for Hepatitis B Virus (HBV) Infection? a Survey of Physician Knowledge, Attitudes and Beliefs About CDC Guidelines (2009) (0)
- PANCREAS, BILIARY TRACT, AND LIVER Increased Risk of Pancreatic Adenocarcinoma After Acute Pancreatitis (2014) (0)
- Tu1500 - Risk of Hepatocellular Cancer Recurrence in HCV Patients Treated with Direct-Acting Antiviral Agents in a United States Veteran Population (2018) (0)
- 637 Temporal Trends of Non-Alcoholic Fatty Liver Disease Related Hepatocellular Carcinoma in Veteran Affairs (VA) Population (2014) (0)
- Abstract 14043: Association of Non-Alcoholic Steatohepatitis Assessed by Fib-4 Index and Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study (2020) (0)
- Cirrhosis Quality Collaborative. (2022) (0)
- Sa355 POSTMENOPAUSAL WOMEN HAVE THE HIGHEST RISK OF ADVANCED NAFLD FIBROSIS (2021) (0)
- 525 THE IMPACT OF RACE ON PANCREATIC CANCER TREATMENT AND SURVIVAL IN THE NATIONWIDE VETERANS AFFAIRS HEALTHCARE SYSTEM (2021) (0)
- Table of contents (2017) (0)
- Mo1446 – An In-Depth Analysis of Hepatocellular Carcinoma Rates in Texas (2019) (0)
- Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance. (2023) (0)
- Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score (2023) (0)
- Effectiveness and utilization of Grazoprevir and Elbasvir in HCV genotype 1 and 4 infection in the veterans affairs healthcare system in the US (2018) (0)
- Tu1512 – Long-Term Outcomes in Patients with Acute Kidney Injury: A Retrospective Cohort Study (2019) (0)
- 530: RISK STRATIFICATION MODEL FOR HEPATOCELLULAR CANCER IN PATIENTS WITH CIRRHOSIS (2022) (0)
- Long‐term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States (2022) (0)
- Tu1555 – Risky Alcohol Consumption is Common Among Persons with Viral Hepatitis in the United States: A Population-Based Study (2019) (0)
- Sa1071 Military Sexual Trauma in Veterans With Hepatitis C: Gender-Based Prevalence and Association With Conditions That Impact Treatment Eligibility (2013) (0)
- Mo1008 Autoimmune Hepatitis and the Incidence of Hepatocellular Carcinoma: A Systematic Review (2015) (0)
- Sa307 NATURAL LANGUAGE PROCESSING IMPROVES THE IDENTIFICATION OF IPMN CYSTS AMONG PATIENTS WITH PANCREATIC CYST DIAGNOSTIC CODES (2021) (0)
- T1017 Quality of Care in Patients with Chronic Hepatitis C Virus Infection (2008) (0)
- Issue Highlights (2006) (0)
- Issue Highlights. (2020) (0)
- Issue Highlights (2022) (0)
- Aggressive utilization of liver allografts: Improved outcomes over time (2020) (0)
- 575: INTERPLAY BETWEEN ALCOHOL DRINKING AND METABOLIC TRAITS IN RISK OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (2022) (0)
- Mo1375: COMPARABLE SURVIVAL FOR VIREMIC AND NON-VIREMIC HCV-HCC LIVER RECIPIENTS IN THE DAA ERA (2022) (0)
- Su1420 Barriers to Hepatitis C Treatment for the Veteran Population in the DAA Era (2016) (0)
- 662 The Impact of Elevated INR on Outcomes in GI Hemorrhage (2010) (0)
- Protecting the stomach from the "toxins" of NSAIDS and anti-platelet agents. (2009) (0)
- Delivering Quality Care to Patients with Cirrhosis: A Practical Guide for Clinicians (2015) (0)
- Tu1050 Treatment and Outcomes of Chronic Hepatitis C (CHC) in the Elderly (2015) (0)
- Issue highlights (2019) (0)
- Tu1504 – Effectiveness of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Genotype 1 Infection Receiving Dialysis (2019) (0)
- Comparable survival for hepatitis C-related hepatocellular carcinoma after liver transplantation irrespective of viremic status. (2022) (0)
- Evaluation of Screening Approaches for Hepatocellular Carcinoma in Cirrhosis Patients from the Veteran's Affairs Health Care System (2017) (0)
- S1377: Very Early Endoscopy (EGD) for Acute Non-Variceal Upper GI Tract Hemorrhage: Sooner May Not Always Be Better (2010) (0)
- Mo1496 WHAT'S IN YOUR DRINK? TEACHING FAMILIES ABOUT SUGAR CONTENT AND NAFLD (2020) (0)
- Issue Highlights. (2019) (0)
- Clinical Outcomes of Patients with LI-RADS 3 or LI-RADS 4 Observations in Patients with Cirrhosis: A Systematic Review. (2022) (0)
- 381 Burden of Non-Alcoholic Fatty Liver Disease in the Veterans Administration (2013) (0)
- The Economic Cost of Cirrhosis (2015) (0)
- NAFLD-Related HCC: How Should the Shift in Epidemiology Change Our Prevention and Surveillance Strategies? (2017) (0)
- Insights on balancing inequities of region-dependent scientific output and publications. (2021) (0)
- Issue Highlights. (2019) (0)
- Role of Extrahepatic Comorbidity and Functional Limitations in Predicting Mortality in Patients With HCV: 2358 (2015) (0)
- The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy (2022) (0)
- Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy. (2023) (0)
- Screening is Associated with Survival Benefit in the in an Silico but Needs Confirmation in an Vivo Analysis (2018) (0)
- Su1379: PARADIGM SHIFT IN ETIOLOGY AND RACE/ETHNICITY-BASED TRENDS IN LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA (2022) (0)
- Statins Use and Overall Survival in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis (2017) (0)
- Utilizing Natural Language Processing (NLP) to Accurately Identify Fatty Liver Disease (2017) (0)
- The Predictive Performance of Contemporary Guideline Recommendations for Helicobacter pylori Testing in a United States Population. (2022) (0)
- Is Liver Transplant Justified at Any MELD Score? (2022) (0)
- M1409: Does Checking for Orthostatic Vital Signs and Performing Rectal Examination Matter in Patients With Upper Gastrointestinal Hemorrhage? (2010) (0)
- 293 - Effectiveness and Utilization of Elbasvir/Grazoprevir in HCV Genotype 1 and 4 Infection in the Veteran Affairs Healthcare System in the United States (2018) (0)
- Mo1891 QUALITY OF TRANSITION CARE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (2020) (0)
- EP1218: REDUCTION IN RACIAL/ETHNIC DISPARITIES FOR LIVER TRANSPLANTATION IN AFRICAN AMERICANS WITH HCC DURING THE DAA ERA (2022) (0)
- Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review (2022) (0)
- 811 – Risk of Hepatic Disease Progression in Patients with Nonalcoholic Fatty Liver (NAFLD)-Related Cirrhosis (2019) (0)
- Anniversary Tribute From the Editors of Clinical Gastroenterology and Hepatology. (2017) (0)
- Increased short and medium term risk of pancreatic adenocarcinoma following acute pancreatitis (2013) (0)
- Issue Highlights. (2018) (0)
- The chosen and the unchosen: How eligibility for liver transplant influences the lived experiences of patients with advanced liver disease. (2022) (0)
- Mo1445 – The Performance of Triple Biomarkers (AFP, AFP-3, DCP) for Early Detection of Hepatocellular Carcinoma (HCC). A Prospective Cohort Phase 3 Biomarker Study in the United States (2019) (0)
- Covering the year in CGH: 2019. (2019) (0)
- 466 Statins Are Underutilized in Patients With Nonalcoholic Fatty Liver Disease and Dyslipidemia (2015) (0)
- T1020 HCV Antiviral Treatment Among US Veterans with Chronic Hepatitis C Infection: Patient, Provider, and Facility Predictors (2008) (0)
- Sa1387: SUPPLEMENTAL TESTOSTERONE THERAPY USAGE AMONG MALE VETERANS WITH HCV-RELATED LIVER DISEASE USING VA HEALTHCARE ASSOCIATED WITH REDUCED RELATIVE RISK OF DEVELOPING INCIDENT HEPATCELLULAR CARCINOMA (2022) (0)
- Su1373: UTILIZATION OF DRUG OVERDOSE DONORS FOR LIVER TRANSPLANTATION DURING COVID-19 PANDEMIC (2022) (0)
- T1022 Lack of Association Between Chronic Hepatitis C Virus Infection and Chronic Kidney Disease (2008) (0)
- Mo1043 Outcomes of Non-Variceal Upper Gastrointestinal Hemorrhage During Nights, Weekends, and Holidays (2012) (0)
- Our New President-Hashem El-Serag, MD, MPH, AGAF. (2019) (0)
- Measuring Quality of Care in Patients with Nonvariceal Upper GI Hemorrhage (NVUGIH): Development of An Explicit Quality Indicator Set (2009) (0)
- M1000 Completion of Hepatitis C Virus (HCV) Treatment in Community Based Practice—An Insight Into the Effectiveness of Treatment (2009) (0)
- A learning curve in using orphan liver allografts for transplantation (2020) (0)
- CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection (2011) (0)
- 574 – Acute-On-Chronic Liver Failure Requires Nonstandard Exception Points for Liver Transplantation Listing (2019) (0)
- Reply to: "Model for end-stage liver disease-sodium in acute-on-chronic liver failure". (2020) (0)
- Presentation of the AGA William Beaumont Prize in Gastroenterology to David Y. Graham, MD. (2021) (0)
- Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference. (2023) (0)
- Late Presentation of Biliary Stricture After Liver Transplantation: 540 (2010) (0)
- Sa1670 - Expression of Pattern Recognition Receptor Pathway Genes and Colorectal Neoplasms (2018) (0)
- 18: Lack of Association Between Chronic Hepatitis C Virus Infection and Chronic Kidney Disease (2008) (0)
- Mo1275 A New Lab Based Algorithm for HCC Surveillance in Patients With Cirrhosis (2014) (0)
- EP1214: EARLY LIVING DONOR LIVER TRANSPLANT PROVIDES HIGHEST OVERALL SURVIVAL BENEFIT IN LOW MELD PATIENTS AWAITING LIVER TRANSPLANTATION (2022) (0)
- Su1955 - One-Carbon Metabolism Nutrients in Relation to Mucosa-associated Gut Microbiome in Healthy Individuals (2018) (0)
- Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era. (2022) (0)
- Mo1895 Primary Prophylaxis With Non-Selective Beta-Blockers in Patients With Cirrhosis—A Chasm Between Efficacy and Effectiveness (2015) (0)
- 869: PROGNOSIS AND CLINICAL CORRELATES OF OUTCOMES IN U.S. PATIENTS WITH INDETERMINATE PHASE CHRONIC HEPATITIS B VIRUS INFECTION (2022) (0)
- Sa1576 - Readmission Rates Following Gastroparesis-Related Hospitalizations in a National us Cohort (2018) (0)
- Telehealth interventions in patients with chronic liver diseases: a systematic review. (2023) (0)
- 340 SYSTEMATIC REVIEW AND META-ANALYSIS OF COHORT STUDIES EXAMINING THE TIME TO DECOMPENSATION IN PATIENTS WITH COMPENSATED NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) CIRRHOSIS (2021) (0)
- Mo1248 Psychosocial Interventions to Achieve Abstinence in Patients With Chronic Liver Disease and Alcohol Use Disorders: A Systematic Review (2015) (0)
- M1525: Variations in the Process of Care Among Patients With Nonvariceal Upper GI Hemorrhage (2010) (0)
- Tu1495 – Real-World Effectiveness of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Genotype 4 Infection: Results from a Veterans Affairs Population (2019) (0)
- Issue Highlights. (2018) (0)
- S0206 Association Between Common Non-Antibiotic Drugs Use and the Adherent Gut Microbiota (2020) (0)
- Two mental models of integrated care for advanced liver disease: qualitative study of multidisciplinary health professionals (2022) (0)
- Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection (2022) (0)
- Abstract 3265: Healthy eating index 2005 and the mucosa associated gut microbiome in healthy individuals (2018) (0)
- Su062 THE ASSOCIATION BETWEEN CHRONIC AND NEW-ONSET DIABETES AND PANCREATIC CANCER CARE OUTCOMES IN THE NATIONWIDE VETERANS AFFAIRS HEALTHCARE SYSTEM (2021) (0)
- 435: EARLY IMPACT OF MMAT-3 POLICY ON LIVER TRANSPLANT OUTCOMES FOR HEPATOCELLULAR CARCINOMA (2022) (0)
- AGA Clinical Practice Update on Interaction Between Oral Direct‐Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review (2020) (0)
- Mo1901 Clinical Outcomes of Hepatitis B Co-Infection in a United States Cohort With Hepatitis C (2012) (0)
- W1773 State of Treatment for Hepatocellular Carcinoma in Patients with HCV Infection in the Department of Veterans Affairs (2009) (0)
- Significant improvements, but consistent disparities in survival for African Americans after liver transplantation (2022) (0)
- Issue Highlights. (2015) (0)
- Utilizing a Multidisciplinary Tumor Board for the Management of Hepatocellular Carcinoma is Associated with Improved Outcomes (2017) (0)
- Su1627 PREDICTION OF 1- AND 3-YEAR MORTALITY IN PATIENTS WITH CIRRHOSIS: USE OF MACHINE LEARNING VS. OTHER APPROACHES (2020) (0)
- Su1611 PURSUING PATIENT-CENTERED CARE FOR ADVANCED LIVER DISEASE: A QUALITATIVE STUDY OF CLINICIANS' PRACTICES AND PERSPECTIVES (2020) (0)
- Alcohol-Associated Liver Disease Mortality Rates by Race Before and During the COVID-19 Pandemic in the US (2023) (0)
- 336 EFFECT OF ANTI-DIABETES MEDICATIONS ON THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (2020) (0)
- 955 – Effectiveness of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Genotype 1 Inffection Who Receive Opioid Agonist Therapy: Treatment Utilization and the Impact of Concomitant Psychiatric Medications (2019) (0)
- An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma (2022) (0)
- Cost-effectiveness in hepatitis B. Authors' reply (2005) (0)
- 708 National Patterns and Predictors of Liver Biopsy use in Patients With Chronic Hepatitis C in the Department of Veterans Affairs (2010) (0)
- T1005 Quality of Care in Spontaneous Bacterial Peritonitis (2010) (0)
- T1016 Burden of Cirrhosis in a National Sample of Patients with Chronic Hepatitis C (2008) (0)
- Issue Highlights. (2017) (0)
- Reply to: "The role of the model for end-stage liver disease sodium score and joint models for 90-day mortality prediction in in patients with acute-on-chronic liver failure". (2020) (0)
- Su1079 Changes in the Incidence and Prevalence of Cirrhosis in the National Veterans Administration Over a Decade: 2002-2012 (2015) (0)
- Incidence of Hepatocellular Carcinoma in Primary Biliary Cirrhosis: A Systematic Review: 2199 (2015) (0)
- Issue Highlights. (2018) (0)
- Issue highlights (2022) (0)
- T1951 Does the Completion of Nasogastric Lavage (NGL) Improve Outcomes in GI Hemorrhage (2009) (0)
- Novel histologic findings in the ringed esophagus are the likely basis for the endoscopic features (2003) (0)
- Low Insurance Coverage Among Hepatitis C (HCV)-Positive Individuals in the United States (2011) (0)
- Tu1325: BEHAVIORAL WEIGHT LOSS INTERVENTIONS FOR PATIENTS WITH NAFLD: A SYSTEMATIC SCOPING REVIEW TO INCREASE THEIR UNDERSTANDING AND USE IN RESEARCH AND PRACTICE. (2022) (0)
- Effectiveness of Hepatitis C Virus (HCV) Antiviral Treatment in Veterans With HIV-HCV Coinfection (2011) (0)
- Mo1401 - Impact of Acid-Reducing Agents on Effectiveness of Elbasvir/Grazoprevir in a us Veterans Affairs Population with Hepatitis C Virus Infection (2018) (0)
- M1001 Quality of Diagnosis and Evaluation-Related Care in Patients with Chronic Hepatitis C Virus Infection (2009) (0)
- Impact of acid-reducing agents on effectiveness of Elbasvir/Grazoprevir in treating US veterans affairs population with hepatitis C virus (2018) (0)
- T1015 Rate and Predictors of Erythropoietic Growth Factors Use in Chronic Hepatitis C Patients with Treatment Induced Anemia (2008) (0)
- The Cost-Effectiveness of IV Versus PO Proton Pump Inhibitor (PPI) Therapy in the Management of High-Risk Ulcer Hemorrhage (2005) (0)
- Incidence and prevalence of extrahepatic manifestations of HCV (2018) (0)
- Su374 THE PREVALENCE AND SEVERITY OF METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN THE VA PRIMARY CARE SETTING (2021) (0)
- New diagnosis of chronic pancreatitis: Risk of missing a pancreatic cancer (2013) (0)
- Tu1674 The Validity of HCC Diagnosis Codes in Chronic Hepatitis B Patients in the Veterans Health Administration (2016) (0)
- Changing Temporal Trends of Gastroparesis-Related Emergency Department Visits and Inpatient Hospitalizations in a National U.S. Cohort: 1239 (2017) (0)
- Actionable Solutions to Achieve Health Equity in Chronic Liver Disease. (2023) (0)
- Sa1870 Cirrhosis Is Underrecognized in Patients Subsequently Diagnosed With HCC (2015) (0)
- Mo1249: EVALUATING GAPS IN THE PANCREATIC CANCER DIAGNOSIS PATHWAY: A STUDY OF EMERGENCY PRESENTATIONS (2022) (0)
- Issue Highlights (2022) (0)
- 538 IMPROVING HELICOBACTER PYLORI TESTING IN PATIENTS WITH ACUTE UPPER GI BLEEDING DUE TO PEPTIC ULCER DISEASE (POSTER PRESENTATION) (2020) (0)
- The Association between Caffeine Intake and the Colonic Mucosa-Associated Gut Microbiota in Humans—A Preliminary Investigation (2023) (0)
- Transplanting Hepatitis B Surface Antigen Positive Livers in the U.S.: Outcomes and Opportunities. (2023) (0)
- Linking Quality of Hepatitis C Virus Care to Treatment and Virologic Response (2011) (0)
- Health-Related Quality Of Life In Chronic Hepatitis C Patients With Depression (2014) (0)
- Tu1268: LONGITUDINAL ASSESSMENT OF SEROLOGICAL RESPONSE AFTER THREE DOSES OF SARS-COV-2 MRNA VACCINE IN LIVER TRANSPLANT RECIPIENTS (2022) (0)
- Reply (2021) (0)
- Issue Highlights. (2019) (0)
- Abstract #445 Testosterone Supplementation in Cirrhosis: A Systematic Review of Randomized Clinical Trials (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Fasiha Kanwal?
Fasiha Kanwal is affiliated with the following schools:
